title: Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome.
authors.forename: Theoharis C
authors.initials: TC
authors.lastname: Theoharides
authors.forename: Shahrzad
authors.initials: S
authors.lastname: Asadi
authors.forename: Zuyi
authors.initials: Z
authors.lastname: Weng
authors.forename: Bodi
authors.initials: B
authors.lastname: Zhang
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D004347:Drug Interactions / Q000502:physiology; D015673:Fatigue Syndrome, Chronic / Q000188:drug therapy* / Q000378:metabolism; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000378:metabolism; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors